UnknownNot Applicable

Understanding the Impact of Death Conditions Linked to the COVID-19 Crisis on the Grieving Process in Bereaved Families

100 participantsStarted 2024-03

Plain-language summary

This study aims to analyze the grieving process of people who have lost a close first degree relative, understand the impact of death conditions and model a "theory of mourning" in the context of the COVID-19 crisis .

Who can participate

Age range

15 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Bereaved person who lost a close relative (child, adolescent, adult) since March 2020 * Age over 15 years old * First degree relative (husband-wife or equivalent, father-mother, son-daughter, brother-sister) * A bereaved person who is in at least one of the following conditions: * Unable to visit the hospital if hospitalized OR * Unable to travel to the home/EPHAD/hospital OR * Wish not to travel for personal reasons OR * Failure to perform funeral rites OR * Failure to respect the wishes of the deceased and his or her own wishes OR * Inability to see the deceased OR * Opportunity to participate in the funeral OR * Unable to say goodbye OR * Inability to communicate via telephone and/or smartphone OR * Unable to repatriate the body to the country or region of origin * Relative who died (child, adolescent, adult) between March 2020 and March 2021 with Covid-19 or other life-threatening conditions * Relative who died in an inpatient or outpatient setting (EPHAD, home or other structure) * French or non-French speaking bereaved person Exclusion Criteria: * Presence of a pathology preventing good elocution during the interview: * Presence of a neurological pathology (e.g. dementia, Alzheimer's, aphasia, dysphasia) * Presence of an unstabilised psychiatric disorder * Person under guardianship or curatorship

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Identify the most traumatic aspects for bereaved families and better identify risk factors that may complicate the grieving process and contribute to the development of possible psychopathology.

Timeframe: 9 months

Trial details

NCT IDNCT05566366

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12

Contact for this trial

Carla DE STEFANO, Dr

+33148 96 44 61 carla.destefano@aphp.fr

View on ClinicalTrials.gov More Psychological Disorder trials

Who can participate

Age range

15 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.